News & Updates

Epstein‒Barr virus (EBV) viral load (VL) monitoring can help lower the incidence of post-transplant lymphoproliferative disease (PTLD) following liver transplant in adults, suggests a study.

An online cross-sectional survey involving antivaxxers, conspiracy theorists, and flat earthers reveals how these people are more likely to believe in false causes of cancer, indicating an association between digital misinformation and consequent erroneous health decisions.

Delivery of continuous, in situ–targeted, ultrahigh concentration of antibiotics (CITA) is a safe and effective therapy for patients with pocket infection who are neither suited nor willing to undergo extraction of implanted cardiovascular electronic device, reports a study.

The combination of tixagevimab and cilgavimab (Tix-Cil) protects immunocompromised patients with suboptimal immune responses to vaccines from COVID-19 complications, results of a study have shown.

As the dust settles from the SARS-CoV-2 pandemic, the lurking threat of antimicrobial resistance (AMR) once again rears its ugly head. Weighing in on this topic is Professor Dr Sasheela Sri La Sri Ponnampalavanar, Infectious Disease Professor, University Malaya Medical Centre (UMMC). Below is an excerpt from her bylined piece titled ‘Tackling the Next Global and Public Health Threat After COVID-19 – Antimicrobial Resistance (AMR).’

Viral prophylaxis with valacyclovir 1 g three times daily following allogeneic haematopoietic cell transplantation (HCT) results in a lower incidence of clinically significant cytomegalovirus (CMV) infection as compared with acyclovir, according to a study.